Skip to content. | Skip to navigation

National Cancer Institute U.S. National Institutes of Health www.cancer.gov

Navigation

Personal tools

You are here: Home / Protocols / Ornithine decarboxylase (ODC) Polymorphism and Breast and Prostate Cancer

Ornithine decarboxylase (ODC) Polymorphism and Breast and Prostate Cancer

101

No coordinating investigator defined.

No involved investigator sites defined.

UNKNOWN
Prostate and Urologic Cancers Research Group

There are currently no biomarkers annotated for this protocol.

No datasets are currently associated with this protocol.


2016 EDRN PI Orientation

The New and Continuing EDRN Principal Investigator Orientation will take on a date and location to be determined.